Immune modulation could explain how experimental Alzheimer's therapy works

Posted by Leanne Kodsman on

In a July 8, 2013 press release, researchers at the University of Kentucky Sanders-Brown Center on Aging, led by Donna Wilcock, announced they have recently published a new paper in the Journal of Neuroscience detailing an advance in treatment for Alzheimer's disease.

The Gammagard IVIg is a therapy that has been investigated in the treatment of Alzheimer's, but was poorly understood. The UK researchers started investigating the mechanism in regard to how it acts in the brain to decrease deposits of amyloid, a key element in Alzheimer's pathology.


In a July 8, 2013 press release, researchers at the University of Kentucky Sanders-Brown Center on Aging, led by Donna Wilcock, announced they have recently published a new paper in the Journal of Neuroscience detailing an advance in treatment for Alzheimer's disease.

The Gammagard IVIg is a therapy that has been investigated in the treatment of Alzheimer's, but was poorly understood. The UK researchers started investigating the mechanism in regard to how it acts in the brain to decrease deposits of amyloid, a key element in Alzheimer's pathology.

Researchers introduced IVIg directly into the brains of mice that possessed the human gene which allows amyloid plaques to build. According to the press release, 'They found that IVIg lowers amyloid deposits in the brains of the mice over the course of seven days. Their data suggest that the modulation of inflammation in the brain by IVIg is a key event that leads to the reduction in amyloid deposition.'

The scientists hypothesize that the IVIg acts as an immune modulator.

This research shows that modulating the immune response within the brain will help ameliorate the Alzheimer's pathology.

    Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.


Related Posts

In Case You Missed It ... Reference Roundup!
The next big thing: it's what you do. The biological research materials you need to dis...
Read the Article
The Impact of Anti-Hypertension Drug Aliskiren on Measuring Soluble (Pro)renin
Did you know? This study used the Human Prorenin ELISA Kit for Non-Plasma Samples from ...
Read the Article
Measuring VACV and ACV in Mouse and Human Plasma
Did you know? For this study, Single Donor Human Plasma was obtained commercially from ...
Read the Article

← Older Post Newer Post →